PhD in Epidemiology, Environmental Sciences, Health Economics, Health Sciences, Health Technology Assessment, Life Sciences, Pharmacy Practice, Population Sciences, Public Health, Statistics
Any Masters Degree B.E, B.Tech, B.Pharma, MBA, PGD in Management with at least 02 years of experience with having minimum 60% marks OR The candidate should either have a Bachelors degree in science, commerce with at least 03 years of experience with having minimum 60% marks may also attend.
M.Sc in Biotechnology, Biochemistry and any Biological Sciences or M.Tech in any Biological Sciences. The candidates should have qualified for any National Level Eligibility test such as to apply for the above position.
Senior scientist-II will work on isolation, purification of known and unknown impurities/compounds by preparative HPLC and characterization of molecules using various analytical technique and Analytical Method Development for in process samples received from synthetic Lab.
He, she will be responsible for providing Therapeutic Area workstream leads with administrative support on pre-defined projects. The Project Manager will set and develop the operational aspects of the project, develop, and monitor timelines, milestones and project metrics and is responsible for managing the projects from an operational perspective from the development and initiation phases through implementation and completion within scope provided by Medical Directors who remains responsible and accountable for the project content.
To ensure that the products are manufactured and stored as per appropriate documents in order to obtain the required quality. To ensure that the production records are reviewed as per current procedures.
Develop forecasts for focused therapeutic areas using patient-based forecast models, and ensure alignment on forecast assumptions and other critical analytical assessments with client business partners including Marketing, Sales, Market Access and Pricing, Market Research, Global Marketing and Insight, Finance, and Sales Operations
Achieve and exceed the sales targets on a consistent basis through effective implementation of the sales promotion strategies and scientific initiatives. Constantly update the knowledge of disease and product area so as to facilitate scientific discussion with stakeholders to enhance productivity levels as expected by the Company.
A new study from Karolinska Institutet shows that heart failure mortality has decreased in Sweden over the last 20 years. The study has been published in the European Journal of Heart Failure.
A national study has shown that heart failure mortality has decreased in Sweden over the last two decades. Despite these improvements, the prognosis for heart failure patients remains worrying – 25 percent of those diagnosed in 2022 died within a year.
The evidence is clear; individuals should get vaccinated if they have conditions that place them at risk for severe disease. For older adults and those with chronic conditions, RSV should be considered as serious as the flu, and they should get vaccinated